FDA.reportPublic FDA data

HUMAN IMMUNOGLOBULIN G

Substance profile for UNII 66Y330CJHS, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
66Y330CJHS
Preferred term
HUMAN IMMUNOGLOBULIN G
Registry number
308067-58-5
Ingredient type
INGREDIENT SUBSTANCE

Chemical And Database Identifiers#

RxCUI
1426680
PubChem
0
NCIt
C80829
INN ID
0
ITIS
180092
NCBI
9606

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1426680https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1426680
NCI ThesaurusC80829https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C80829
FDA Substance Registration System66Y330CJHShttps://precision.fda.gov/uniisearch/srs/unii/66Y330CJHS

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
HUMAN IMMUNOGLOBULIN GACTIVE INGREDIENT66Y330CJHSOctagam, Immune Globulin Intravenous (Human) 5% Liquid Preparation Initial U.S. Approval: 2004 - These highlights do not include all the information needed to use Octagam, Immune Globulin Intravenous (Human), safely and effectively. See full prescribing information for Octagam.4
HUMAN IMMUNOGLOBULIN GACTIVE MOIETY66Y330CJHSOctagam, Immune Globulin Intravenous (Human) 5% Liquid Preparation Initial U.S. Approval: 2004 - These highlights do not include all the information needed to use Octagam, Immune Globulin Intravenous (Human), safely and effectively. See full prescribing information for Octagam.4
HUMAN IMMUNOGLOBULIN GACTIVE MOIETY66Y330CJHSOctagam, Immune Globulin Intravenous (Human) 5% Liquid Preparation Initial U.S. Approval: 2004 - These highlights do not include all the information needed to use Octagam, Immune Globulin Intravenous (Human), safely and effectively. See full prescribing information for Octagam.1
HUMAN IMMUNOGLOBULIN GACTIVE INGREDIENT66Y330CJHSOctagam, Immune Globulin Intravenous (Human) 5% Liquid Preparation Initial U.S. Approval: 2004 - These highlights do not include all the information needed to use Octagam, Immune Globulin Intravenous (Human), safely and effectively. See full prescribing information for Octagam.1
Human Immunoglobulin GACTIVE INGREDIENT66Y330CJHSGAMUNEX-C (IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 10% CAPRYLATE CHROMATOGRAPHY PURIFIED) INJECTION [GRIFOLS USA, LLC]24
Human Immunoglobulin GACTIVE MOIETY66Y330CJHSGAMUNEX-C (IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 10% CAPRYLATE CHROMATOGRAPHY PURIFIED) INJECTION [GRIFOLS USA, LLC]24
Human Immunoglobulin GACTIVE INGREDIENT66Y330CJHSGAMASTAN S/D (IMMUNE GLOBULIN (HUMAN)) INJECTION [GRIFOLS USA, LLC]21
Human Immunoglobulin GACTIVE MOIETY66Y330CJHSGAMASTAN S/D (IMMUNE GLOBULIN (HUMAN)) INJECTION [GRIFOLS USA, LLC]21
Human Immunoglobulin GACTIVE INGREDIENT66Y330CJHSGAMMAKED (HUMAN IMMUNOGLOBULIN G) INJECTION [KEDRION BIOPHARMA, INC]18
Human Immunoglobulin GACTIVE MOIETY66Y330CJHSGAMMAKED (HUMAN IMMUNOGLOBULIN G) INJECTION [KEDRION BIOPHARMA, INC]18
Human Immunoglobulin GACTIVE INGREDIENT66Y330CJHSPRIVIGEN (HUMAN IMMUNOGLOBULIN G) LIQUID [CSL BEHRING AG]18
Human Immunoglobulin GACTIVE MOIETY66Y330CJHSPRIVIGEN (HUMAN IMMUNOGLOBULIN G) LIQUID [CSL BEHRING AG]18
HUMAN IMMUNOGLOBULIN GACTIVE INGREDIENT66Y330CJHSFLEBOGAMMA DIF (HUMAN IMMUNOGLOBULIN G) INJECTION, SOLUTION [GRIFOLS USA, LLC]13
HUMAN IMMUNOGLOBULIN GACTIVE MOIETY66Y330CJHSFLEBOGAMMA DIF (HUMAN IMMUNOGLOBULIN G) INJECTION, SOLUTION [GRIFOLS USA, LLC]13
Human Immunoglobulin GACTIVE INGREDIENT66Y330CJHSFLEBOGAMMA DIF (HUMAN IMMUNOGLOBULIN G) INJECTION, SOLUTION [GRIFOLS USA, LLC]13
Human Immunoglobulin GACTIVE MOIETY66Y330CJHSFLEBOGAMMA DIF (HUMAN IMMUNOGLOBULIN G) INJECTION, SOLUTION [GRIFOLS USA, LLC]13
Human immunoglobulin GACTIVE MOIETY66Y330CJHSHIZENTRA (HUMAN IMMUNOGLOBULIN G) LIQUID [CSL BEHRING AG]13
HUMAN IMMUNOGLOBULIN GACTIVE INGREDIENT66Y330CJHSHIZENTRA (HUMAN IMMUNOGLOBULIN G) LIQUID [CSL BEHRING AG]13
HUMAN IMMUNOGLOBULIN GACTIVE MOIETY66Y330CJHSGAMMAPLEX (HUMAN IMMUNOGLOBULIN G) SOLUTION [BIO PRODUCTS LABORATORY LIMITED]12
HUMAN IMMUNOGLOBULIN GACTIVE INGREDIENT66Y330CJHSGAMMAPLEX (HUMAN IMMUNOGLOBULIN G) SOLUTION [BIO PRODUCTS LABORATORY LIMITED]12
HUMAN IMMUNOGLOBULIN GACTIVE MOIETY66Y330CJHSCARIMUNE NANOFILTERED (HUMAN IMMUNOGLOBULIN G) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CSL BEHRING AG]8
HUMAN IMMUNOGLOBULIN GACTIVE INGREDIENT66Y330CJHSCARIMUNE NANOFILTERED (HUMAN IMMUNOGLOBULIN G) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CSL BEHRING AG]8
HUMAN IMMUNOGLOBULIN GACTIVE INGREDIENT66Y330CJHSGAMMAGARD (HUMAN IMMUNOGLOBULIN G) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION]8
HUMAN IMMUNOGLOBULIN GACTIVE MOIETY66Y330CJHSGAMMAGARD (HUMAN IMMUNOGLOBULIN G) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION]8
Human Immunoglobulin GACTIVE INGREDIENT66Y330CJHSVIVAGLOBIN (HUMAN IMMUNOGLOBULIN G) SOLUTION [CSL BEHRING LLC]8
Human Immunoglobulin GACTIVE MOIETY66Y330CJHSVIVAGLOBIN (HUMAN IMMUNOGLOBULIN G) SOLUTION [CSL BEHRING LLC]8
HUMAN IMMUNOGLOBULIN GACTIVE MOIETY66Y330CJHSBIVIGAM (HUMAN IMMUNOGLOBULIN G) INJECTION, SOLUTION [BIOTEST PHARMACEUTICALS CORPORATION]7
HUMAN IMMUNOGLOBULIN GACTIVE INGREDIENT66Y330CJHSBIVIGAM (HUMAN IMMUNOGLOBULIN G) INJECTION, SOLUTION [BIOTEST PHARMACEUTICALS CORPORATION]7
HUMAN IMMUNOGLOBULIN GACTIVE INGREDIENT66Y330CJHSGAMMAGARD S/D (HUMAN IMMUNOGLOBULIN G) KIT [BAXTER HEALTHCARE CORPORATION]7
HUMAN IMMUNOGLOBULIN GACTIVE MOIETY66Y330CJHSGAMMAGARD S/D (HUMAN IMMUNOGLOBULIN G) KIT [BAXTER HEALTHCARE CORPORATION]7
HUMAN IMMUNOGLOBULIN GACTIVE MOIETY66Y330CJHSWINRHO (RHO (D) IMMUNE GLOBULIN) LIQUID [CANGENE BIOPHARMA INC.]7
HUMAN IMMUNOGLOBULIN GACTIVE INGREDIENT66Y330CJHSWINRHO (RHO (D) IMMUNE GLOBULIN) LIQUID [CANGENE BIOPHARMA INC.]7
HUMAN IMMUNOGLOBULIN GACTIVE INGREDIENT66Y330CJHSGAMMAGARD S/D (HUMAN IMMUNOGLOBULIN G) KIT [BAXTER HEALTHCARE CORPORATION]6
HUMAN IMMUNOGLOBULIN GACTIVE MOIETY66Y330CJHSGAMMAGARD S/D (HUMAN IMMUNOGLOBULIN G) KIT [BAXTER HEALTHCARE CORPORATION]6
HUMAN IMMUNOGLOBULIN GACTIVE INGREDIENT66Y330CJHSGAMMAGARD S/D (HUMAN IMMUNOGLOBULIN G) KIT [BAXTER HEALTHCARE CORPORATION]6
HUMAN IMMUNOGLOBULIN GACTIVE MOIETY66Y330CJHSGAMMAGARD S/D (HUMAN IMMUNOGLOBULIN G) KIT [BAXTER HEALTHCARE CORPORATION]6
HUMAN IMMUNOGLOBULIN GACTIVE INGREDIENT66Y330CJHSGAMMAGARD S/D (HUMAN IMMUNOGLOBULIN G) KIT [BAXTER HEALTHCARE CORPORATION]5
HUMAN IMMUNOGLOBULIN GACTIVE MOIETY66Y330CJHSGAMMAGARD S/D (HUMAN IMMUNOGLOBULIN G) KIT [BAXTER HEALTHCARE CORPORATION]5
HUMAN IMMUNOGLOBULIN GACTIVE MOIETY66Y330CJHSOCTAGAM IMMUNE GLOBULIN (HUMAN) (IMMUNE GLOBULIN) SOLUTION [OCTAPHARMA USA INC]5
HUMAN IMMUNOGLOBULIN GACTIVE INGREDIENT66Y330CJHSOCTAGAM IMMUNE GLOBULIN (HUMAN) (IMMUNE GLOBULIN) SOLUTION [OCTAPHARMA USA INC]5
HUMAN IMMUNOGLOBULIN GACTIVE INGREDIENT66Y330CJHSGAMMAGARD S/D (HUMAN IMMUNOGLOBULIN G) KIT [BAXTER HEALTHCARE CORPORATION]2
HUMAN IMMUNOGLOBULIN GACTIVE MOIETY66Y330CJHSGAMMAGARD S/D (HUMAN IMMUNOGLOBULIN G) KIT [BAXTER HEALTHCARE CORPORATION]2
HUMAN IMMUNOGLOBULIN GACTIVE INGREDIENT66Y330CJHSGAMMAGARD S/D (HUMAN IMMUNOGLOBULIN G) KIT [BAXTER HEALTHCARE CORPORATION]2
HUMAN IMMUNOGLOBULIN GACTIVE MOIETY66Y330CJHSGAMMAGARD S/D (HUMAN IMMUNOGLOBULIN G) KIT [BAXTER HEALTHCARE CORPORATION]2
HUMAN IMMUNOGLOBULIN GACTIVE INGREDIENT66Y330CJHSOCTAGAM IMMUNE GLOBULIN (HUMAN) (IMMUNE GLOBULIN) SOLUTION [OCTAPHARMA USA INC]2
HUMAN IMMUNOGLOBULIN GACTIVE MOIETY66Y330CJHSOCTAGAM IMMUNE GLOBULIN (HUMAN) (IMMUNE GLOBULIN) SOLUTION [OCTAPHARMA USA INC]2
HUMAN IMMUNOGLOBULIN GACTIVE INGREDIENT66Y330CJHSGAMMAGARD S/D (HUMAN IMMUNOGLOBULIN G) KIT [BAXTER HEALTHCARE CORPORATION]1
HUMAN IMMUNOGLOBULIN GACTIVE MOIETY66Y330CJHSGAMMAGARD S/D (HUMAN IMMUNOGLOBULIN G) KIT [BAXTER HEALTHCARE CORPORATION]1
HUMAN IMMUNOGLOBULIN GACTIVE INGREDIENT66Y330CJHSGAMMAGARD S/D (HUMAN IMMUNOGLOBULIN G) KIT [BAXTER HEALTHCARE CORPORATION]1
HUMAN IMMUNOGLOBULIN GACTIVE MOIETY66Y330CJHSGAMMAGARD S/D (HUMAN IMMUNOGLOBULIN G) KIT [BAXTER HEALTHCARE CORPORATION]1
HUMAN IMMUNOGLOBULIN GACTIVE MOIETY66Y330CJHSHYQVIA (HUMAN IMMUNEGLOBULIN G AND HYALURONIDASE (HUMAN RECOMBINANT)) KIT HYQVIA (HUMAN IMMUNEGLOBULIN G AND HYALURONIDASE (HUMAN RECOMBINANT)) KIT [BAXTER HEALTHCARE CORPORATION]1
HUMAN IMMUNOGLOBULIN GACTIVE INGREDIENT66Y330CJHSHYQVIA (HUMAN IMMUNEGLOBULIN G AND HYALURONIDASE (HUMAN RECOMBINANT)) KIT HYQVIA (HUMAN IMMUNEGLOBULIN G AND HYALURONIDASE (HUMAN RECOMBINANT)) KIT [BAXTER HEALTHCARE CORPORATION]1